A study evaluating paritaprevir/ombitasvir/ritonavir, dasabuvir with ribavirin in patients with compensated liver cirrhosis with hepatitis B virus + hepatitis C virus coinfection: a national cohort study.
Phase of Trial: Phase IV
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin (Primary)
- Indications Hepatitis B; Hepatitis C
- Focus Therapeutic Use
- 08 Jul 2017 New trial record